A review of the key trends from the recent investor day
Summarizing takeaways from Alignment, Astrana, Clover, CVS, HCA, Humana, Oscar, Tenet, and UHG
Top takeaways from public company presentations at JPMorgan Healthcare Conference 2024.
Diving into some of the key questions posed by the deal - is the MA Golden Age over, Oak's J-Curve, and CVS's broader strategy
Looking back at Bright's early strategy to understand whether its individual exchange business was always doomed from the start
Our reflections on a conversation with Ro's CEO, Zachariah Reitano, about all things Ro
Perspective on the commercial challenges that have plagued +Oscar's launch and learning lessons for others
A deep dive into Humana’s 2022 investor day and what’s in store for the MA insurer.
Looking at the strategic implications of Signify for Amazon, CVS, and UHG
Our key strategic takeaways from earnings calls
A summary of our key takeaways from earnings calls this week
Our perspective on the key strategic questions posed by Amazon's announced $3.9 billion acquisition of One Medical
